Deardorf Caren 4
4 · Magenta Therapeutics, Inc. · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Deardorf Caren
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-15+75,000→ 75,000 totalExercise: $3.19Exp: 2032-02-14→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is February 1, 2022.